Activist investor Bill Ackman finds himself targeted by other hedge fund giants. But Wednesday, it got even worse for Ackman.
Stocks wrapped up the final trading day of the month on a flat note, but still logged their best July since 2010, as the Federal Reserve said it will maintain its bond-buying policy in its ongoing effort to bolster the economy.
Shares of Herbalife could more than triple from its current levels, Robert Chapman of Chapman Capital says.
The battle over Herbalife intensified as George Soros has taken a large long position in the nutritional supplements maker, according to sources.
Bill Ackman is risking his investors' money on a "vendetta" against Herbalife, Robert Chapman of Chapman Capital says.
The acquisition is said to be one of the billionaire's top three holdings, reports CNBC's Scott Wapner.
In hedge fund manager William Ackman's first comments since January on his bet against Herbalife, he told CNBC, "I haven't covered a single share."
William Ackman's firm Pershing Square Capital Management has acquired a 9.8 percent position in $22 billion industrial gas company Air Products & Chemicals.
CNBC's Herb Greenberg has the latest details from Herblife's conference call, as hedge fund titan Bill Ackman questions the company's operating income growth.
Hedge fund manager Bill Ackman on Tuesday questioned the strength of Herbalife's earnings, saying income growth was weak.
Capital Management's William Ackman is raising questions about Herbalife's independent auditor, reports CNBC's Scott Wapner.
Some of the names on the move ahead of the open.
Stocks kicked off the week on a weak note as investors hesitated to jump in ahead of the Federal Reserve meeting and a slew of key economic reports.
Herbalife on Monday delivered its 18th straight earnings beat and raised its full-year guidance, but third-quarter guidance came in weaker.
Check out which companies are making headlines after the bell Monday:
Herbalife is reporting a Q2 earnings beat with EPS of $1.41 ex-items vs. $1.18 estimate and revenue of $1.22 billion. CNBC's Herb Greenberg, shares his opinion. Tim Ramey, D.A. Davidson, weighs in, as well.
Herbalife is seeing volatile activity on earnings. CNBC's Josh Lipton has the data.
The FMHR traders have the play on Wynn Resorts, Whole Foods and advertising stocks. And CNBC's Herb Greenberg explains why he is watching Herbalife's earnings instead of the disagreement between Carl Icahn and Bill Ackman.
U.S. stock index futures ticked lower on Monday, ahead of the Federal Reserve meeting and another heavy week for second quarter earnings.
If you're looking for a slow summer day, you won't find it this week.